PubRank

J Egido

Author PubWeight™ 191.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 2000 2.12
2 Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 2001 2.10
3 Angiotensin II and renal fibrosis. Hypertension 2001 1.87
4 Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997 1.84
5 Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 1994 1.84
6 Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003 1.79
7 IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 1980 1.75
8 Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001 1.72
9 Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils. Immunology 1980 1.69
10 Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 2000 1.51
11 Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001 1.50
12 HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998 1.45
13 Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. Kidney Int 2006 1.45
14 Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 2001 1.42
15 Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998 1.41
16 Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2011 1.40
17 Familial IgA nephropathy associated with bilateral sensorineural deafness. Am J Kidney Dis 1992 1.39
18 Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. Immunopharmacology 1982 1.39
19 Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol 1982 1.35
20 Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 1999 1.34
21 Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. Clin Exp Immunol 1983 1.34
22 Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 2006 1.34
23 T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol 1983 1.32
24 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998 1.31
25 Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001 1.30
26 A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. Proc Eur Dial Transplant Assoc 1980 1.26
27 Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994 1.23
28 Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage 2004 1.18
29 Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 2000 1.17
30 Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997 1.15
31 Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol 1982 1.15
32 Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol 2009 1.13
33 Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 1984 1.13
34 Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000 1.12
35 Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm 2011 1.12
36 Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 2001 1.12
37 Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001 1.12
38 High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage 2001 1.11
39 Evidence for the involvement of IgE-basophil system in acute serum sickness. Clin Exp Immunol 1976 1.10
40 Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 2000 1.08
41 Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997 1.08
42 Vasoactive hormones and renal sclerosis. Kidney Int 1996 1.07
43 Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996 1.07
44 Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993 1.06
45 In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. Kidney Int 1999 1.04
46 Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol 1996 1.04
47 Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 2002 1.01
48 Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999 1.01
49 Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996 1.01
50 Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 1993 1.00
51 Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2002 1.00
52 Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994 1.00
53 Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. J Lipid Mediat 1990 0.99
54 ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 1995 0.98
55 Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int 2000 0.98
56 The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 1999 0.98
57 Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates. Immunology 1984 0.97
58 Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hypertens Suppl 1994 0.97
59 Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 2001 0.97
60 Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis 2006 0.95
61 Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 2008 0.95
62 Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am J Pathol 1993 0.95
63 A fibrin based model for rheumatoid synovitis. Ann Rheum Dis 2003 0.93
64 Effect of the flavonoid quercetin on cadmium-induced hepatotoxicity. Food Chem Toxicol 2008 0.93
65 ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am J Pathol 1998 0.93
66 In-vitro basophil degranulation in drug-suspected acute renal failure. Lancet 1977 0.93
67 Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 1995 0.93
68 Contribution of apoptotic cell death to renal injury. J Cell Mol Med 2002 0.93
69 Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy. Transplant Proc 2008 0.92
70 Immunopathogenetic aspects of IgA nephropathy. Adv Nephrol Necker Hosp 1983 0.92
71 The role of IgA and IgG immune complexes in IgA nephropathy. Nephron 1984 0.92
72 Presence in normal human urine of a hypotensive and platelet-activating phospholipid. Am J Physiol 1983 0.92
73 Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis. Rheumatology (Oxford) 2003 0.91
74 Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contrib Nephrol 2001 0.90
75 Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms. Atherosclerosis 2010 0.90
76 Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int 1997 0.90
77 Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis. Am J Pathol 1996 0.90
78 Detection of immediate hypersensitivity in rabbits by direct basophil degranulation. J Allergy Clin Immunol 1977 0.90
79 Binding kinetics of monomeric and aggregated IgG to Kupffer cells and hepatocytes of mice. Immunology 1984 0.90
80 Inhibitory effect of cinnamon, clove, lemongrass, oregano and palmarose essential oils on growth and fumonisin B1 production by Fusarium proliferatum in maize grain. Int J Food Microbiol 2003 0.90
81 Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. Am J Pathol 2001 0.89
82 Nephrotic syndrome complicating chronic visceral leishmaniasis: re-emergence in patients with AIDS. Clin Nephrol 2008 0.89
83 Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPARα in the associated hypertrophy. J Proteomics 2011 0.89
84 Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases. Kidney Int Suppl 1998 0.89
85 Renal expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in a rat model of tubulointerstitial damage. Kidney Int 1999 0.88
86 A simple method for determining polymeric IgA-containing immune complexes. J Immunol Methods 1983 0.88
87 Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 1987 0.88
88 Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem 2009 0.88
89 EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis 2004 0.88
90 Alteration of energy substrates and ROS production in diabetic cardiomyopathy. Mediators Inflamm 2013 0.88
91 Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage 2008 0.87
92 Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis 2002 0.87
93 Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol 1996 0.87
94 Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats. Clin Exp Immunol 1980 0.87
95 Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy. Clin Exp Immunol 1987 0.87
96 MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple. Cytokine Growth Factor Rev 2012 0.87
97 Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist. Nephrol Dial Transplant 1989 0.87
98 Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor. Eur J Pharmacol 1992 0.87
99 Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Am Soc Nephrol 1997 0.87
100 Angiotensin II: a double-edged sword in inflammation. J Nephrol 2000 0.86
101 Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis. Arthritis Rheum 2000 0.86
102 The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy. Clin Immunol Immunopathol 1992 0.86
103 Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. Kidney Int Suppl 1998 0.86
104 Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates. Immunology 1982 0.86
105 Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. Nephrol Dial Transplant 1998 0.86
106 Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Kidney Int 1999 0.85
107 Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem Toxicol 2006 0.85
108 Role of platelet-activating factor in adriamycin-induced nephropathy in rats. Eur J Pharmacol 1987 0.85
109 The central role of nuclear factor-kappa B in mesangial cell activation. Kidney Int Suppl 1999 0.85
110 Immunological studies in a familial IgA nephropathy. Clin Exp Immunol 1983 0.85
111 An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int 1996 0.85
112 Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Eur J Neurol 2012 0.85
113 Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus. Ann Rheum Dis 1980 0.85
114 Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. Atherosclerosis 2010 0.85
115 Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin Exp Immunol 1998 0.84
116 Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. Clin Exp Immunol 1992 0.84
117 Rat serum sickness: possible role of inflammatory mediators allowing deposition of immune complexes in the glomerular basement membrane. Clin Exp Immunol 1982 0.84
118 Evidence of high polymeric IgA levels in serum of patients with Berger's disease and its modification with phenytoin treatment. Proc Eur Dial Transplant Assoc 1979 0.84
119 IL-1-like production in adriamycin-induced nephrotic syndrome in the rat. Clin Exp Immunol 1992 0.84
120 Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 1996 0.83
121 Immunological abnormalities in healthy relatives of patients with IgA nephropathy. Am J Nephrol 1985 0.83
122 Lipophilic statins induce apoptosis of human vascular smooth muscle cells. Kidney Int Suppl 1999 0.83
123 Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy. Contrib Nephrol 1993 0.83
124 Phenytoin in IgA nephropathy: a long-term controlled trial. Nephron 1984 0.83
125 High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 1994 0.83
126 Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. J Lipid Mediat Cell Signal 1996 0.83
127 Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 2001 0.83
128 Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain. Semin Nephrol 1987 0.83
129 [Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy]. Nefrologia 2009 0.82
130 Non-platelet-mediated vascular actions of 1-O-alkyl-2-acetyl-sn-3-glyceryl phosphorycholine (a synthetic PAF). Agents Actions 1981 0.82
131 Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994 0.82
132 Inhibition by L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils. Biochem Biophys Res Commun 1991 0.82
133 Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. Int J Cardiol 2009 0.82
134 [Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage]. Nefrologia 2009 0.82
135 The role of platelet-activating factor (PAF) in experimental glomerular injury. Lipids 1991 0.82
136 SAMe restores the changes in the proliferation and in the synthesis of fibronectin and proteoglycans induced by tumour necrosis factor alpha on cultured rabbit synovial cells. Br J Rheumatol 1997 0.82
137 Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis. J Immunol 2000 0.82
138 Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure. Kidney Int 2001 0.81
139 Recurrent acute postinfectious glomerulonephritis. Clin Nephrol 2006 0.81
140 Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 2001 0.81
141 Salmonella enteritidis empyema complicating lupus pleuritis. Postgrad Med J 1991 0.81
142 New kids in the block: the role of FasL and Fas in kidney damage. J Nephrol 1999 0.81
143 Is there a role for specific anti-TNF strategies in glomerular diseases? Nephrol Dial Transplant 1995 0.81
144 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. Minerva Med 2012 0.81
145 Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy. Clin Exp Immunol 1982 0.81
146 Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. Contrib Nephrol 1995 0.81
147 Modulation of renal tubular cell survival: where is the evidence? Curr Med Chem 2006 0.81
148 Tyrphostins as potential therapeutic agents for acute kidney injury. Curr Med Chem 2010 0.81
149 Clinical significance of polymeric and monomeric IgA complexes in patients with IgA nephropathy. Am J Kidney Dis 1986 0.81
150 The intercrine superfamily and renal disease. Kidney Int Suppl 1993 0.81
151 Role and regulation of apoptotic cell death in the kidney. Y2K update. Front Biosci 2000 0.80
152 Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 1997 0.80
153 Lethal activity of FADD death domain in renal tubular epithelial cells. Kidney Int 2006 0.80
154 Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy. Am J Kidney Dis 1991 0.80
155 ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect. Nephrol Dial Transplant 2000 0.80
156 Effects of disodium cromoglycate and antihistamines in acute serum sickness of rabbits. Proc Eur Dial Transplant Assoc 1977 0.80
157 [Internal carotid artery agenesis and multiple aneurysms in the posterior communicating artery]. Neurologia 1994 0.80
158 Presence of circulating antibodies against brush border antigens (Fx1A) in a patient with membranous nephropathy and bilateral pyeloureteral stenosis. Comparison with idiopathic membranous nephropathy. Nephrol Dial Transplant 1992 0.80
159 IgA nephropathy: association of a history of macroscopic hematuria episodes with increased production of polymeric IgA. Nephron 1987 0.80
160 Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A. J Am Soc Nephrol 1998 0.80
161 Stimulation of Fc(alpha) receptors induces tyrosine phosphorylation of phospholipase C-gamma(1), phosphatidylinositol phosphate hydrolysis, and Ca2+ mobilization in rat and human mesangial cells. J Immunol 1996 0.79
162 Phenytoin in the treatment of IgA mesengial glomerulonephritis (Berger's disease) Clin Nephrol 1981 0.79
163 Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells. Eur J Pharmacol 1996 0.79
164 Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. Atherosclerosis 2012 0.79
165 IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells. Clin Exp Immunol 1995 0.79
166 The importance of the Fc receptors for IgA in the recognition of IgA by mouse liver cells: its comparison with carbohydrate and secretory component receptors. Immunology 1986 0.78
167 Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria. Kidney Int 2006 0.78
168 Beneficial effect of fibronectin administration on chronic nephritis in rats. Arthritis Rheum 1990 0.78
169 Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron 1992 0.78
170 From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm. Thromb Haemost 2014 0.78
171 Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis. J Am Soc Nephrol 1997 0.78
172 DNA release and appearance of antinuclear antibodies in chronic hemodialysis patients. Nephron 1982 0.78
173 Regulation of matrix proteins and impact on vascular structure. Curr Hypertens Rep 2000 0.78
174 A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice. J Rheumatol 1999 0.78
175 The effect of the injection of a synthetic platelet-activating factor (PAF-acether) on the fate of IgG aggregates in mice. Immunology 1982 0.78
176 Antifibroproliferative effect of tenidap in chronic antigen-induced arthritis. Arthritis Rheum 1997 0.78
177 Apoptosis in renal diseases. Front Biosci 1996 0.77
178 Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy. Immunology 1989 0.77
179 Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin Exp Immunol 1995 0.77
180 [TWEAK, the facilitator of acute kidney injury]. Nefrologia 2008 0.77
181 Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy. Contrib Nephrol 1995 0.77
182 Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. Clin Exp Immunol 1989 0.77
183 Handling of IgA immune aggregates by liver cells. Contrib Nephrol 1984 0.77
184 Immunological studies of experimental IgA nephropathy in mice. Adv Exp Med Biol 1987 0.77
185 Cartilage and bone biological markers in the synovial fluid of osteoarthritic patients after hyaluronan injections in the knee. Clin Chim Acta 2001 0.77
186 Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial. Cerebrovasc Dis 2006 0.77
187 [Statins, inflammation and atherosclerotic damage]. Nefrologia 2004 0.77
188 Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patients. Nephron Clin Pract 2012 0.77
189 TWEAK and the kidney: the dual role of a multifunctional cytokine. Adv Exp Med Biol 2011 0.77
190 PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage. Ann Rheum Dis 1997 0.77
191 IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 1995 0.77
192 Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease. J Nutr Health Aging 2016 0.76
193 Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney Int 1996 0.76
194 Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. Hypertension 1997 0.76
195 Poststroke sexual dysfunction and quality of life. Stroke 1999 0.75
196 Urinary excretion of platelet-activating factor in human and experimental nephrosis. Nephrol Dial Transplant 1996 0.75
197 Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells. Immunology 1988 0.75
198 Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy. Immunology 1990 0.75
199 Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis. Clin Exp Immunol 1995 0.75
200 Chemokines, chemokine receptors and renal disease. Kidney Int 1999 0.75
201 Detection of cross-reactive idiotypes in blood and kidneys of patients with IgA nephropathy. Adv Exp Med Biol 1987 0.75
202 [Angiotensin II : a key peptide in vascular and renal failure]. Nefrologia 2003 0.75
203 T-cell alterations in immunoglobulin A nephropathy. Int J Clin Pharmacol Res 1992 0.75
204 [Influence of glucagon and insulin in the metabolism of lipids in patients under hemodialysis and renal transplants]. Rev Clin Esp 1977 0.75
205 Urticaria-associated recurrent glomerulonephritis with a favorable response to indomethacin. Nephron 1992 0.75
206 [Pathogenic factors in diabetic nephropathy. Where do we come from and where are we headed?]. Nefrologia 2001 0.75
207 Usefulness of serum interleukin 2 receptor levels in renal allograft recipients. Transplant Proc 1992 0.75
208 [Segmental renal hypoplasia and arterial hypertension. Study of 8 cases]. Actas Urol Esp 1979 0.75
209 Immune abnormalities of IgA in six families with IgA nephropathy. Adv Exp Med Biol 1987 0.75
210 Evidence of sensitized basophils in renal transplanted patients. Transplantation 1980 0.75
211 [Aseptic thrombosis of the cerebral venous sinuses and polycythemia vera]. Neurologia 1995 0.75
212 Pathogenic mechanisms of glomerulonephritis: apoptotic cell death. Rev Clin Esp 2000 0.75
213 Elevated plasma fibronectin levels in rats with immune and toxic glomerular diseases. Ren Fail 1990 0.75
214 Delayed graft function and cotrimoxazole. Transplant Proc 2011 0.75
215 Presence of specific IgA immune complexes in IgA nephropathy. Contrib Nephrol 1984 0.75
216 [Localized scleroderma (morphea) and septic arthritis. Clinical manifestations of Lyme borreliosis seen in El Ferrol]. Enferm Infecc Microbiol Clin 1992 0.75
217 Diabetes and previous stroke: hazards for intravenous thrombolysis? Eur J Neurol 2011 0.75
218 Heymann nephritis of rats: is a vasopermeability mechanism really needed for immune complex deposition? Proc Eur Dial Transplant Assoc 1979 0.75
219 [Role of polymeric IgA in the pathogenesis of IgA nephropathy]. Nephrologie 1983 0.75
220 Involvement of platelet-activating factor in renal processes. Adv Lipid Res 1989 0.75
221 Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis. Lab Invest 1999 0.75
222 Abnormalities of immune regulation in patients with IgA mesangial glomerulonephritis (Berger's disease). Proc Eur Dial Transplant Assoc 1983 0.75
223 The 80-kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor-alpha (TNF-alpha) in cultured mesangial cells. Clin Exp Immunol 1997 0.75
224 Disturbances of IgA immune regulation in lymphocytes from mucosae and peripheral blood in patients with IgA nephropathy. Semin Nephrol 1987 0.75
225 [Incidence of strains of Neisseria gonorrhoeae producing penicillinase (NGPP) in Ferrol. Distribution by serogroups]. Enferm Infecc Microbiol Clin 1989 0.75
226 [New immunopathogenic aspects of IgA nephropathy]. Bull Acad Natl Med 1990 0.75
227 Expression and synthesis of cross-reactive idiotypic antibodies by peripheral blood lymphocytes and their suppression by anti-idiotypes in patients with IgA nephropathy. J Immunol 1991 0.75
228 IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates. Lipids 1991 0.75
229 Delayed clearance of specific polymeric IgA immune complexes in patients with IgA nephropathy. Proc Eur Dial Transplant Assoc 1983 0.75
230 Ciprofloxacin-associated tubulointerstitial nephritis with linear tubular basement membrane deposits. Nephron 1992 0.75
231 [Oligomeganephronia associated with congenital eye and skeletal abnormalities]. Actas Urol Esp 1979 0.75
232 Acute renal failure in patient treated with anti-tumour necrosis factor alpha. Nefrologia 2011 0.75
233 The emerging role of parathyroid hormone-related protein as a renal regulating factor. Nephrol Dial Transplant 2000 0.75